Interestingly, increased phospho-tau has been reported in ALS patients, especially those with cognitive impairment [30,31], which suggests that further analysis of a potential relationship between TDP-43 and tau in mouse models and in human cases might be warranted. Here, MAPT is linked to Cognitive impairment.